Vitamin C

Why It Matters for Longevity

Vitamin C is the primary water-soluble antioxidant in human plasma: it regenerates vitamin E, enhances non-heme iron absorption by up to 3-fold, and is an essential cofactor for collagen and carnitine synthesis. At adequate levels it protects against oxidative DNA damage.

Khaw et al.'s (2001) EPIC-Norfolk prospective study of nearly 20,000 adults found that plasma vitamin C was inversely associated with all-cause mortality: each 20 µmol/L increment was associated with a 13% reduction in risk of dying from any cause, with individuals in the highest quartile having ~20% lower all-cause mortality. This association was dose-dependent and independent of confounders.

At pharmacological concentrations (achieved only via intravenous administration), ascorbate acts as a pro-drug delivering hydrogen peroxide selectively to tumor tissues. Padayatty et al. (2004) demonstrated that pharmacological ascorbate concentrations — achievable intravenously but not orally — selectively killed cancer cells in culture, providing the mechanistic basis for the clinical IV vitamin C protocols discussed by Longo.

Supplementation vs. Dietary Sources: What the Evidence Actually Shows

A 2022 umbrella review by Xu et al. synthesized 76 meta-analyses covering 63 health outcomes. Dietary vitamin C intake was consistently associated with reduced all-cause mortality, lower cardiovascular disease risk, and decreased risk for several cancers including esophageal, gastric, cervical, and lung cancers. Supplemental vitamin C, by contrast, showed a more mixed picture: while it shared some benefits, supplementation was associated with increased breast cancer risk and elevated kidney stone risk in susceptible individuals. The authors concluded that whole-food vitamin C sources — where ascorbate travels alongside bioflavonoids and other co-factors — carry a more favorable risk-benefit profile than isolated supplements for most people.

A 2023 meta-analysis by Xu et al. (PMID 37111066) pooled 44 RCTs with 26,540 participants and found that vitamin C supplementation was associated with a 13% reduction in all-cause mortality (RR 0.87, 95% CI 0.78–0.97). The subgroup with the most robust signal was sepsis: mortality in sepsis trials dropped by 26% (RR 0.74, 95% CI 0.59–0.91), a finding that survived trial sequential analysis. The general-population effect did not meet the threshold for confirmation by sequential analysis, which the authors interpret as requiring further large-scale trials before routine supplementation is recommended for prevention.

Common Cold: What the Data Support

The Cochrane review by Hemilä and Chalker (2013) analyzed 29 trials of regular supplementation (10,708 participants) and found that vitamin C does not reduce the incidence of colds in the general population (RR 0.97, 95% CI 0.94–1.00). However, regular supplementation modestly shortened cold duration by 8% in adults and 14% in children. In athletes under extreme physical stress — marathon runners, skiers, soldiers on subarctic exercises — the incidence reduction reached 52% (RR 0.48, 95% CI 0.35–0.64 in 598 participants). Taking vitamin C therapeutically after cold symptoms appear showed no consistent benefit. The practical implication is that daily maintenance doses (200–500 mg from food or supplements) reduce cold severity marginally; higher therapeutic doses taken reactively do not.

Collagen Synthesis and Structural Roles

Vitamin C acts as an obligate cofactor for prolyl hydroxylase and lysyl hydroxylase, the enzymes that hydroxylate proline and lysine residues in procollagen chains. Without hydroxylation, collagen triple helices cannot cross-link properly, producing mechanically weak connective tissue — the underlying defect in scurvy. Plasma ascorbate concentrations above ~50 µmol/L appear sufficient to saturate these enzymes under normal physiological conditions. The same cofactor role applies to carnitine biosynthesis (via trimethyllysine hydroxylase), linking vitamin C status to mitochondrial fatty acid oxidation.

Antioxidant Network Integration

Vitamin C's antioxidant action is not isolated. When vitamin E (alpha-tocopherol) neutralizes a lipid peroxyl radical in a cell membrane, it becomes the tocopheroxyl radical — a relatively stable but still reactive species. Ascorbate in the aqueous phase donates a hydrogen atom to regenerate alpha-tocopherol, becoming the ascorbyl radical, which is far less reactive and can be reduced back to ascorbate by NADH-dependent enzymes. This two-step recycling creates a synergistic antioxidant network that spans both lipid and aqueous compartments. The same regeneration logic applies to other phenolic antioxidants; ascorbate effectively extends the functional lifespan of the entire antioxidant pool.

How to Use It

Pairs well with lemon, bell peppers, spinach. Use as a nutrient in your daily meals according to the Longevity Diet guidelines. Dietary sources: bell peppers (190 mg/100g), kiwi (93 mg/100g), citrus (53 mg/100g), broccoli (89 mg/100g).

What to Pair It With

Synergies

• Iron-Rich Foods (synergy): Vitamin C reduces ferric to ferrous iron, enhancing non-heme iron absorption by up to 3-fold; critical pairing for plant-based diets.
• Vitamin E (synergy): Vitamin C regenerates oxidized vitamin E (tocopheroxyl radical) back to its active form, creating a synergistic antioxidant network.
• Collagen-Containing Foods (synergy): Vitamin C is an essential cofactor for prolyl and lysyl hydroxylase enzymes required for collagen cross-linking and structural integrity.

Flavor Profile

Category: micronutrient / supplement.

The Science

• Khaw et al., 2001, Lancet: Plasma vitamin C inversely associated with all-cause mortality in EPIC-Norfolk (n=19,496); each 20 µmol/L increment reduced all-cause mortality risk by ~13%.
• Padayatty et al., 2004, Ann Intern Med: Intravenous ascorbate at pharmacological concentrations achieves plasma levels ~25x higher than oral dosing and produces cytotoxic effects selectively in cancer cells via pro-oxidant hydrogen peroxide generation.
• Xu et al., 2022, Int J Food Sci Nutr: Umbrella review of 76 meta-analyses (51 papers, 63 outcomes) found dietary vitamin C consistently associated with reduced all-cause mortality and cancer risk; supplemental vitamin C carried a distinct risk profile including elevated breast cancer and kidney stone risk.
• Xu et al., 2023, Nutrients: Meta-analysis of 44 RCTs (n=26,540) found vitamin C supplementation associated with 13% lower all-cause mortality (RR 0.87, 95% CI 0.78–0.97) and 26% lower mortality in sepsis trials (RR 0.74, 95% CI 0.59–0.91).
• Hemilä & Chalker, 2013, Cochrane Database Syst Rev: Regular vitamin C supplementation reduced cold duration by 8% in adults and 14% in children (11,000+ participants) but did not reduce incidence in the general population; 52% incidence reduction observed in athletes under extreme physical stress.

References

1. Khaw KT, Bingham S, Welch A, et al. Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. Lancet. 2001;357(9257):657-63. PMID: 11247548. doi:10.1016/S0140-6736(00)04128-3
2. Padayatty SJ, Sun H, Wang Y, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004;140(7):533-7. PMID: 14982000. doi:10.7326/0003-4819-140-7-200404060-00010
3. Xu K, Peng R, Zou Y, et al. Vitamin C intake and multiple health outcomes: an umbrella review of systematic reviews and meta-analyses. Int J Food Sci Nutr. 2022;73(5):644-653. PMID: 35291895. doi:10.1080/09637486.2022.2048359
4. Xu C, Yi T, Tan S, et al. Association of Oral or Intravenous Vitamin C Supplementation with Mortality: A Systematic Review and Meta-Analysis. Nutrients. 2023;15(8):1848. PMID: 37111066. doi:10.3390/nu15081848
5. Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2013;2013(1):CD000980. PMID: 23440782. doi:10.1002/14651858.CD000980.pub4

Key Nutrients